Commodore-Capital-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "NUVL",
  "CNTA",
  "ALKS",
  "ORIC",
  "TYRA",
  "NRIX",
  "MNMD",
  "PHVS",
  "NGNE",
  "AVTX",
  null,
  "SRRK",
  "SYRE",
  "APGE",
  "IKT",
  null,
  "AGIO",
  "SLDB",
  "SLNO",
  "COGT",
  "ELVN",
  "VTGN",
  "VRDN",
  "XENE",
  "ORKA",
  "VERA",
  "PCVX",
  "CRDF",
  "CELC",
  "CLDX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 31
Total Value: 1357083846
Accession Number: 0001831942-25-000005
Form Type: 13F-HR
CIK: commodore-capital-lp
Manager Name: Commodore-Capital-Lp

Data Enrichment

94% identified

29 identified2 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

31 positions • $1.4B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 2

Sort by:

Merus N.V.

MRUS|N5749R100

Shares:4.5M

Value:$188.3M

% of Portfolio:13.9% ($188.3M/$1.4B)

Nuvalent, Inc.

NUVL|670703107

Shares:1.9M

Value:$131.6M

% of Portfolio:9.7% ($131.6M/$1.4B)

Enliven Therapeutics, Inc.

ELVN|29337E102

Shares:4.7M

Value:$92.0M

% of Portfolio:6.8% ($92.0M/$1.4B)

SOLENO THERAPEUTICS INC

SLNO|834203309

Shares:1.1M

Value:$82.2M

% of Portfolio:6.1% ($82.2M/$1.4B)

Xenon Pharmaceuticals Inc.

XENE|98420N105

Shares:2.3M

Value:$78.0M

% of Portfolio:5.7% ($78.0M/$1.4B)

Alkermes plc.

ALKS|G01767105

Shares:1.9M

Value:$64.4M

% of Portfolio:4.7% ($64.4M/$1.4B)

AGIOS PHARMACEUTICALS, INC.

AGIO|00847X104

Shares:2.2M

Value:$64.0M

% of Portfolio:4.7% ($64.0M/$1.4B)

Vaxcyte, Inc.

PCVX|92243G108

Shares:1.6M

Value:$62.3M

% of Portfolio:4.6% ($62.3M/$1.4B)

Vera Therapeutics, Inc.

VERA|92337R101

Shares:2.6M

Value:$61.5M

% of Portfolio:4.5% ($61.5M/$1.4B)

Celldex Therapeutics, Inc.

CLDX|15117B202

Shares:3.2M

Value:$58.1M

% of Portfolio:4.3% ($58.1M/$1.4B)

Scholar Rock Holding Corp

SRRK|80706P103

Shares:1.7M

Value:$56.1M

% of Portfolio:4.1% ($56.1M/$1.4B)

Cogent Biosciences, Inc.

COGT|19240Q201

Shares:8.9M

Value:$53.3M

% of Portfolio:3.9% ($53.3M/$1.4B)

Viridian Therapeutics, Inc.\DE

VRDN|92790C104

Shares:3.6M

Value:$48.5M

% of Portfolio:3.6% ($48.5M/$1.4B)

Nurix Therapeutics, Inc.

NRIX|67080M103

Shares:4.0M

Value:$47.3M

% of Portfolio:3.5% ($47.3M/$1.4B)

Centessa Pharmaceuticals plc

CNTA|152309100

Shares:2.4M

Value:$34.0M

% of Portfolio:2.5% ($34.0M/$1.4B)

Spyre Therapeutics, Inc.

SYRE|00773J202

Shares:2.0M

Value:$32.1M

% of Portfolio:2.4% ($32.1M/$1.4B)

Pharvaris N.V.

PHVS|N69605108

Shares:1.9M

Value:$30.0M

% of Portfolio:2.2% ($30.0M/$1.4B)

Mind Medicine (MindMed) Inc.

MNMD|60255C885

Shares:4.5M

Value:$26.5M

% of Portfolio:2.0% ($26.5M/$1.4B)

Solid Biosciences Inc.

SLDB|83422E204

Shares:5.8M

Value:$21.6M

% of Portfolio:1.6% ($21.6M/$1.4B)

10919W405

Shares:500.0K

Value:$18.0M

% of Portfolio:1.3% ($18.0M/$1.4B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Merus N.V.(MRUScusipN5749R100)	4.5M	QoQ +15.45% (+598.7K) YoY +2.58% (-112.8K)	All Managers (Combined)	$188.3M	13.9% ($188.3M/$1.4B)	QoQ +15.56% (+$25.4M) YoY -4.10% (-$8.1M)
Nuvalent, Inc.(NUVLcusip670703107)	1.9M	QoQ +14.39% (+233.4K) YoY +24.68% (+367.2K)	All Managers (Combined)	$131.6M	9.7% ($131.6M/$1.4B)	QoQ +3.63% (+$4.6M) YoY +17.76% (+$19.8M)
Enliven Therapeutics, Inc.(ELVNcusip29337E102)	4.7M	QoQ +11.17% (-470.0K) YoY +17.66% (+701.8K)	All Managers (Combined)	$92.0M	6.8% ($92.0M/$1.4B)	QoQ -2.75% (-$2.6M) YoY +31.64% (+$22.1M)
SOLENO THERAPEUTICS INC(SLNOcusip834203309)	1.1M	QoQ -24.59% (-375.0K) YoY +578.33% (+980.5K)	All Managers (Combined)	$82.2M	6.1% ($82.2M/$1.4B)	QoQ +19.86% (-$13.6M) YoY +1032.40% (+$74.9M)
Xenon Pharmaceuticals Inc.(XENEcusip98420N105)	2.3M	QoQ -15.14% (-415.0K) YoY +7.25% (-157.2K)	All Managers (Combined)	$78.0M	5.7% ($78.0M/$1.4B)	QoQ -27.37% (-$29.4M) YoY -16.41% (-$15.3M)
Alkermes plc.(ALKScusipG01767105)	1.9M	QoQ -15.21% (-350.0K) YoY NEW(+1.9M)	All Managers (Combined)	$64.4M	4.7% ($64.4M/$1.4B)	QoQ -2.65% (-$1.8M) YoY NEW(+$64.4M)
AGIOS PHARMACEUTICALS, INC.(AGIOcusip00847X104)	2.2M	QoQ NEW(+2.2M) YoY NEW(+2.2M)	All Managers (Combined)	$64.0M	4.7% ($64.0M/$1.4B)	QoQ NEW(+$64.0M) YoY NEW(+$64.0M)
Vaxcyte, Inc.(PCVXcusip92243G108)	1.6M	QoQ +1.53% (-25.0K) YoY +91.86% (+790.0K)	All Managers (Combined)	$62.3M	4.6% ($62.3M/$1.4B)	QoQ -53.16% (-$70.7M) YoY +6.05% (+$3.6M)
Vera Therapeutics, Inc.(VERAcusip92337R101)	2.6M	QoQ +30.79% (-603.2K) YoY -19.05% (-603.2K)	All Managers (Combined)	$61.5M	4.5% ($61.5M/$1.4B)	QoQ -25.70% (-$21.3M) YoY -54.91% (-$74.9M)
Celldex Therapeutics, Inc.(CLDXcusip15117B202)	3.2M	QoQ NEW(+3.2M) YoY +269.31% (+2.3M)	All Managers (Combined)	$58.1M	4.3% ($58.1M/$1.4B)	QoQ NEW(+$58.1M) YoY +59.71% (+$21.7M)
Scholar Rock Holding Corp(SRRKcusip80706P103)	1.7M	QoQ +83.68% (+795.0K) YoY NEW(+1.7M)	All Managers (Combined)	$56.1M	4.1% ($56.1M/$1.4B)	QoQ +36.63% (+$15.0M) YoY NEW(+$56.1M)
Cogent Biosciences, Inc.(COGTcusip19240Q201)	8.9M	QoQ +29.22% (-2.0M) YoY +38.40% (+2.5M)	All Managers (Combined)	$53.3M	3.9% ($53.3M/$1.4B)	QoQ -0.76% (-$408.7K) YoY +23.37% (+$10.1M)
Viridian Therapeutics, Inc.\DE(VRDNcusip92790C104)	3.6M	QoQ +50.00% (+1.2M) YoY +86.07% (+1.7M)	All Managers (Combined)	$48.5M	3.6% ($48.5M/$1.4B)	QoQ +5.47% (+$2.5M) YoY +43.25% (+$14.7M)
Nurix Therapeutics, Inc.(NRIXcusip67080M103)	4.0M	QoQ +32.63% (-978.9K) YoY NEW(+4.0M)	All Managers (Combined)	$47.3M	3.5% ($47.3M/$1.4B)	QoQ -16.36% (-$9.3M) YoY NEW(+$47.3M)
Centessa Pharmaceuticals plc(CNTAcusip152309100)	2.4M	QoQ +6.72% (-149.2K) YoY NEW(+2.4M)	All Managers (Combined)	$34.0M	2.5% ($34.0M/$1.4B)	QoQ -8.37% (-$3.1M) YoY NEW(+$34.0M)
Spyre Therapeutics, Inc.(SYREcusip00773J202)	2.0M	QoQ 0.00% (-0) YoY +5.51% (-104.0K)	All Managers (Combined)	$32.1M	2.4% ($32.1M/$1.4B)	QoQ -30.69% (-$14.2M) YoY -55.11% (-$39.4M)
Pharvaris N.V.(PHVScusipN69605108)	1.9M	QoQ 0.00% (-0) YoY +10.80% (-186.4K)	All Managers (Combined)	$30.0M	2.2% ($30.0M/$1.4B)	QoQ -18.10% (-$6.6M) YoY -24.72% (-$9.9M)
Mind Medicine (MindMed) Inc.(MNMDcusip60255C885)	4.5M	QoQ +5.02% (-216.6K) YoY -22.42% (-1.3M)	All Managers (Combined)	$26.5M	2.0% ($26.5M/$1.4B)	QoQ -11.72% (-$3.5M) YoY -51.72% (-$28.4M)
Solid Biosciences Inc.(SLDBcusip83422E204)	5.8M	QoQ NEW(+5.8M) YoY NEW(+5.8M)	All Managers (Combined)	$21.6M	1.6% ($21.6M/$1.4B)	QoQ NEW(+$21.6M) YoY NEW(+$21.6M)
(cusip10919W405)✕	500.0K	QoQ 0.00% (+0) YoY NEW(+500.0K)	All Managers (Combined)	$18.0M	1.3% ($18.0M/$1.4B)	QoQ +0.13% (+$25.0K) YoY NEW(+$18.0M)